Abstract

Guillain-Barré syndrome (GBS) in an immune mediated disease that affects peripheral nerves with possible life-threatening complications. GBS has multiple subtypes including acute inflammatory demyelinating polyradiculoneuropathy (AIDP), acute motor axonal neuropathy (AMAN) and acute motor sensory axonal neuropathy (AMSAN), which can make GBS difficult to diagnose. GBS commonly presents after viral infections such as influenza virus, campylobacter jejuni, and zika virus. GBS commonly presents with a prolonged clinical course leading to increased morbidity among affected patients. It is not surprising that COVID-19 has been connected with multiple cases of GBS, which may alter the recovery course for several patients post-COVID. In this report, we present a case of 69-year-old-female who presented with progressive motor weakness and loss of sensation in her extremities after testing positive for antibodies to COVID-19 one-month prior to presentation. Her presentation and treatment of GBS in the setting of COVID-19 is an example of one of the many COVID-19 complications and sheds light on the prolonged recovery course that we may experience as clinicians in the wake of this pandemic.

Highlights

  • Coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]

  • While SARS-CoV2 has been observed to cause a respiratory illness in many cases, neurological complications of the virus have been increasingly reported, especially in those patients with more severe infection

  • A viral pandemic is often linked to a rise in cases of Guillain-Barré syndrome (GBS) as seen with recent outbreaks of zika virus and Middle East respiratory syndrome virus (MERS-CoV) [7,8,9]

Read more

Summary

Introduction

Neuromuscular disorder classically characterized by an acute, ascending paralysis after a recent bacterial or viral infection. A viral pandemic is often linked to a rise in cases of GBS as seen with recent outbreaks of zika virus and Middle East respiratory syndrome virus (MERS-CoV) [7,8,9]. We present an atypical case of GBS secondary to COVID-19 infection

Case Presentation
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.